Related Experiment Video
Updated: Mar 20, 2026
05:44
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
2.6K
Pregnancy in the Setting of Multiple Sclerosis
Continuum (Minneapolis, Minn.)
|June 5, 2016
Summary
Pregnancy and breastfeeding offer a protective immunomodulatory effect for multiple sclerosis (MS) patients, potentially reducing postpartum relapses. Disease-modifying therapies may further mitigate risks before conception.
Area of Science:
- Neurology
- Immunology
- Reproductive Medicine
Background:
- Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
- Reproductive health in women with MS is a significant concern for patients and clinicians.
- Understanding the impact of pregnancy and reproductive interventions on MS disease activity is crucial.
Observation:
- Pregnancy is associated with a significant decrease in MS relapse rates, particularly during the third trimester.
- The postpartum period shows a notable increase in MS relapses.
- Breastfeeding may offer a protective effect against postpartum disease activity.
Findings:
- Disease-modifying therapies (DMTs) are typically discontinued during pregnancy and lactation, with specific exceptions.
- Assisted reproductive technologies (ART) may be associated with an increased risk of MS relapse.
- Pregnancy in women with MS generally proceeds without major obstetric complications, resulting in healthy newborns.
Implications:
- Reproductive planning and management in MS patients require careful consideration of disease activity and treatment strategies.
- The immunomodulatory effects of pregnancy and breastfeeding present potential therapeutic insights.
- Further research is needed to optimize ART and DMT use in women with MS planning pregnancy.
